As a follow-up to yesterday’s blog, here is a list of guidance documents FDA plans to fully publish, and intends to publish in the upcoming fiscal year. Remember, these lists and increased transparency efforts are in part the result of FDA negotiations with industry for the Agency to meet different quantitative and qualitative goals for the medical device industry. This is done in hopes to allow safe and effective devices to the public in a faster, more efficient method.